DORPHAN ^Company

Dorphan S.A. is a company established in 2011 by the Swiss Sanfilippo Foundation with the aim of creating drug candidates for rare genetic diseases. The company conducts research globally to identify and develop preclinical molecules to deliver potential drugs to patients.